Management of Refractory Mandibular Kaposiform Hemangioendothelioma with Sirolimus: A Case Report and Review of the Literature

J Oral Maxillofac Surg. 2021 Oct;79(10):2086.e1-2086.e8. doi: 10.1016/j.joms.2021.05.017. Epub 2021 May 18.

Abstract

Kaposiform hemangioendothelioma (KHE) is a rare vascular neoplasm of intermediate malignancy that generally occurs in infancy and early childhood. Typically, the lesion arises from superficial or deep soft tissues of the extremities, trunk and retroperitoneum. The paucity of reported cases of head and neck KHEs is evidence of the rarity of the disease in this region. We report on the presentation and treatment of KHE in an 11-month-old boy who presented with a mandibular lesion. We include a brief discussion about the differential diagnosis of KHE. Management involved preoperative interventional radiology, surgical excision and chemotherapeutic treatment with Sirolimus. The lesion resolved without evidence of relapse 12 months later.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Child, Preschool
  • Hemangioendothelioma* / diagnostic imaging
  • Hemangioendothelioma* / drug therapy
  • Hemangioendothelioma* / surgery
  • Humans
  • Infant
  • Kasabach-Merritt Syndrome* / diagnostic imaging
  • Kasabach-Merritt Syndrome* / drug therapy
  • Male
  • Sarcoma, Kaposi* / diagnostic imaging
  • Sarcoma, Kaposi* / drug therapy
  • Sirolimus / therapeutic use

Substances

  • Sirolimus

Supplementary concepts

  • Kaposiform Hemangioendothelioma